Like Akap9, Gnb1 is also implicated in kidney disease, where downregulation of the gene is associated with worsened prognosis of clear-cell renal cell carcinoma [20], as well as in resistance to tyrosine kinase inhibitor drugs in human models of kidney cancer [21]. Here, AKAP9 is linked to clear cell renal carcinoma.